Why Vaccine Trials Benefit from Continuous Physiological Monitoring

Why Vaccine Clinical Trials Benefit from Continuous Physiological Monitoring One of the most persistent challenges in vaccine clinical trials is generating precise, timely data across a large and often widely dispersed participant population. Reactogenicity events such as fever, injection site reactions, and fatigue typically emerge and resolve within 24 to 72 hours of dosing, a timeline that often outpaces paper diaries and scheduled follow-up calls.